https://cn.cardiacbiotech.com/changes-in-management-and-directors/2022-10-05T12:48:30-04:00https://cn.cardiacbiotech.com/completion-of-asset-purchase-agreement-and-commencement-of-its-ecg-monitoring-business/2022-10-05T12:49:00-04:00https://cn.cardiacbiotech.com/the-launch-of-my-cardia-ecg-products-and-services-in-thailand/2022-10-05T12:53:56-04:00https://cn.cardiacbiotech.com/distributor-mango-wellness-and-my-cardia-thailand-well-positioned-for-growth-in-2021/2022-10-05T12:53:29-04:00https://cn.cardiacbiotech.com/cb-scientific-inc-cbsc-and-shenzhen-semacare-medical-technology-co-ltd-announce-collaborative-partnership-agreement/2022-10-05T12:04:57-04:00https://cn.cardiacbiotech.com/jeslie-chui-appointed-as-director-of-business-development-asia-pacific/2022-10-05T12:03:24-04:00https://cn.cardiacbiotech.com/distributor-mango-wellness-comes-to-an-agreement-to-provide-services-to-three-major-hospital-chains-in-thailand/2022-10-05T12:57:19-04:00https://cn.cardiacbiotech.com/a-consultant-services-agreement-entered-with-the-dorchester-group-llc/2022-10-05T12:57:41-04:00https://cn.cardiacbiotech.com/launch-of-direct-to-consumer-heart-wellness-check-up-program-in-bangkok-thailand/2022-10-05T12:56:20-04:00https://cn.cardiacbiotech.com/announcing-the-engagement-of-malonebailey-llp/2021-10-05T10:16:43-04:00https://cn.cardiacbiotech.com/paul-danner-appointed-as-chairman/2021-10-28T09:33:20-04:00https://cn.cardiacbiotech.com/announcing-the-addition-of-brooke-martellaro-as-chief-financial-officer/2021-12-14T10:05:28-05:00https://cn.cardiacbiotech.com/application-filed-to-uplist-to-the-otcqb-venture-market/2021-11-16T09:19:42-05:00https://cn.cardiacbiotech.com/announcing-intent-to-convene-a-special-meeting-of-the-stockholders/2022-05-24T09:56:30-04:00https://cn.cardiacbiotech.com/executed-manufacturing-letter-of-intent-with-shenzhen-pump-medical-system-co-ltd/2022-05-24T10:01:13-04:00https://cn.cardiacbiotech.com/entered-beta-testing-phase-for-updated-proprietary-my-cam-cardiac-event-monitor/2022-10-05T11:56:59-04:00https://cn.cardiacbiotech.com/cb-scientific-inc-to-convene-a-special-meeting-of-stockholders-on-friday-january-14-2022/2022-01-04T10:20:48-05:00https://cn.cardiacbiotech.com/cb-scientific-inc-concludes-its-special-meeting-of-stockholders/2022-01-18T09:00:42-05:00https://cn.cardiacbiotech.com/cb-scientific-inc-concludes-its-annual-audit-with-malonebailey-llp/2022-03-15T09:10:13-04:00https://cn.cardiacbiotech.com/cb-scientific-inc-announces-uplist-to-the-otcqb-venture-market/2022-04-06T12:12:03-04:00https://cn.cardiacbiotech.com/cb-scientific-inc-welcomes-james-ott-as-chief-technology-officer/2022-05-03T09:07:20-04:00https://cn.cardiacbiotech.com/enters-regulatory-testing-phase-for-updated-mycam-cardiac-event-monitoring-device/2022-05-24T10:01:08-04:00https://cn.cardiacbiotech.com/cb-scientific-inc-cbsc-and-shenzhen-pump-medical-co-ltd-announce-cooperative-manufacturing-agreement-for-chinese-market/2022-08-23T09:11:57-04:00https://cn.cardiacbiotech.com/cb-scientific-inc-announces-fda-510k-submission-of-enhanced-mycam-cardiac-event-monitor-2/2023-03-29T15:23:45-04:00https://cn.cardiacbiotech.com/cb-scientific-inc-announces-exclusive-canadian-distribution-agreement/2024-01-11T00:00:23-05:00https://cn.cardiacbiotech.com/cb-scientific-inc-concludes-its-annual-meeting-of-stockholders/2024-03-19T08:57:36-04:00https://cn.cardiacbiotech.com/cb-scientific-inc-announces-voluntary-delisting-from-otcqb-venture-market/2024-08-20T15:38:39-04:00https://cn.cardiacbiotech.com/trip-thomas-appointed-as-chief-financial-officer/2024-10-04T18:51:41-04:00https://cn.cardiacbiotech.com/mycardia-at-cardiac-monitor-launch/2025-09-22T23:45:20-04:00https://cn.cardiacbiotech.com/cb-scientific-inc-cbsc-announces-corporate-name-change-to-cardiac-biotech-solutions-inc/2025-05-08T18:44:21-04:00https://cn.cardiacbiotech.com/cardiac-biotech-solutions-inc-cbsc-signs-exclusive-5-year-distribution-agreement-with-noventis-medical-covering-costa-rica-panama-colombia-and-argentina/2025-09-04T13:17:45-04:00https://cn.cardiacbiotech.com/cbsc-announces-375000-purchase-order-and-launch-of-recurring-revenue-program-with-noventis-medical/2025-09-11T12:12:40-04:00https://cn.cardiacbiotech.com/cardiac-biotech-solutions-inc-secures-health-canada-license-for-mycardia-at-device-now-branded-as-cardioholter-at/2025-09-25T11:44:06-04:00https://cn.cardiacbiotech.com/cardiac-biotech-solutions-activates-china-production-pipeline-for-mycardia-at-and-moves-into-final-nmpa-submission-phase/2026-01-15T09:16:21-05:00